Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal

Autor: P Pisa, MJ Cannon, EK Pisa, NR Cooper, RI Fox

Publikováno v: Blood. 79(1)

Severe combined immunodeficient (SCID) mice reconstituted with lymphocytes from Epstein-Barr virus (EBV) negative human donors develop aggressive tumors after the chimeric mice are infected with EBV. The tumors were composed of human B cells that exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a55e96682eb534a3342f3c5edb32b23
https://pubmed.ncbi.nlm.nih.gov/1309425

Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells

Autor: Ad, Santin, Pl, Hermonat, Antonella Ravaggi, Bellone S, Jj, Roman, Jayaprabhu S, Pecorelli S, Gp, Parham, Mj, Cannon

Publikováno v: Europe PubMed Central

Human papillomavirus (HPV) infection represents the most important risk factor for developing cervical cancer. In this study, we examine the potential of full-length E7-pulsed autologous dendritic cells (DCs) to induce antigen-specific CTL responses

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::9a840b3a09a48d7736722eee15e14349
http://europepmc.org/abstract/med/11300476

Intrathecal cytotoxic T-cell immunotherapy for metastatic leptomeningeal melanoma

Autor: Ar, Clemons-Miller, Gs, Chatta, Hutchins L, Ej, Angtuaco, Antonella Ravaggi, Ad, Santin, Mj, Cannon

Publikováno v: Europe PubMed Central

A 49-year-old patient with primary, recurrent melanoma on the lower extremity developed metastatic leptomeningeal melanoma that did not respond to treatment with radiation therapy or intrathecal interleukin 2 (IL-2). Disease was characterized by neur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6721592eda3c85eec1bfa7f355a67ffc
http://europepmc.org/abstract/med/11300492

Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade.

Autor: Tesfay MZ; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA.; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Zhang Y; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Ferdous KU; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Taylor MA; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Cios A; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Shelton RS; Department of Pharmacology, UAMS, Little Rock, AR, USA., Simoes CC; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA.; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Watters CR; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA., Barro O; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA., Elliott NM; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA., Mustafa B; Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Chamcheu JC; School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana Monroe, Monroe, LA, USA., Graham AL; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Washam CL; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Alkam D; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Gies A; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Byrum SD; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Giorgakis E; College of Medicine, Surgery Transplant University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA., Post SR; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA.; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Kelly T; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA.; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA., Ying J; Department of Biostatistics, UAMS College of Public Health, Little Rock, AR, USA., Moaven O; Division of Surgical Oncology, Department of Surgery, Louisiana State University (LSU) Health, New Orleans, LA, USA.; Department of Interdisciplinary Oncology, Louisiana Cancer Research Center, Louisiana State University (LSU) Health, New Orleans, LA, USA.; LSU-LCMC Cancer Center, New Orleans, LA, USA., Chabu CY; Division of Biological Sciences, University of Missouri, Columbia, MO, USA.; Department of Surgery, School of Medicine, University of Missouri, Columbia, MO, USA.; Siteman Cancer Center, Washington University, St. Louis, MO, USA., Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USA., Duda DG; Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA., Roberts LR; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USA., Govindarajan R; Medical Oncology Division, Internal Medicine Department, The University of Arkansas for Medical Sciences, Little Rock, AR, USA., Borad MJ; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA., Cannon MJ; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA.; Department of Microbiology and Immunology, UAMS, Little Rock, AR, USA., Basnakian AG; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA.; Department of Pharmacology, UAMS, Little Rock, AR, USA., Nagalo BM; Department of Pathology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, USA.; The Winthrop P. Rockefeller Cancer Institute, UAMS, Little Rock, AR, USA.

Publikováno v: Molecular therapy. Oncology [Mol Ther Oncol] 2024 Nov 26; Vol. 32 (4), pp. 200913. Date of Electronic Publication: 2024 Nov 26 (Print Publication: 2024).

Delivering the National Diabetes Prevention Program: Assessment of Retention, Physical Activity, and Weight Loss Outcomes by Participant Characteristics and Delivery Modes.

Autor: Ng BP; College of Nursing and Disability Aging and Technology Cluster University of Central Florida, Orlando, Florida, USA.; Division of Diabetes Translation Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ely E; Division of Diabetes Translation Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Papali'i M; Division of Diabetes Translation Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Cannon MJ; Division of Diabetes Translation Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Publikováno v: Journal of diabetes research [J Diabetes Res] 2024 Aug 13; Vol. 2024, pp. 8461704. Date of Electronic Publication: 2024 Aug 13 (Print Publication: 2024).